{"entity":{"type":"insider","cik":"0001291884","url":"/insider/0001291884","json_url":"/insider/0001291884.json","name":"MedImmune Ventures, Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2014-04-01","last":"2017-12-18","span_basis":"filed_date"},"name_variants":[{"name":"MedImmune Ventures, Inc.","source":"filing","n_filings":8,"first_seen":"2014-04-01","last_seen":"2017-12-18"}],"transactions":[{"id":5010331,"accession":"0000899243-17-029061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-029061","line_url":"/filing/0000899243-17-029061#line-1","is_derivative":false,"issuer_cik":"0001291884","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001291884","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":19.75,"price_display":"19.75","price_state":"stated","total_value":3950000.0,"total_display":"3,950,000.00","total_whole":"3,950,000","shares_owned_after":2950630.0,"shares_owned_after_display":"2,950,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-18","scope":"insider"},{"id":5310626,"accession":"0000899243-17-027927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-027927","line_url":"/filing/0000899243-17-027927#line-1","is_derivative":false,"issuer_cik":"0001291884","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001291884","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133906.0,"shares_display":"133,906","price_per_share":19.75,"price_display":"19.75","price_state":"stated","total_value":2644643.5,"total_display":"2,644,643.50","total_whole":"2,644,644","shares_owned_after":3150630.0,"shares_owned_after_display":"3,150,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4352315,"accession":"0000899243-17-027243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-027243","line_url":"/filing/0000899243-17-027243#line-1","is_derivative":false,"issuer_cik":"0001291884","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001291884","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":4002000.0,"total_display":"4,002,000.00","total_whole":"4,002,000","shares_owned_after":3284536.0,"shares_owned_after_display":"3,284,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-20","filed_date":"2017-11-22","scope":"insider"},{"id":4415965,"accession":"0001209191-17-035151","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-035151","line_url":"/filing/0001209191-17-035151#line-2","is_derivative":false,"issuer_cik":"0001291884","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001291884","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1125000.0,"total_display":"1,125,000.00","total_whole":"1,125,000","shares_owned_after":3484536.0,"shares_owned_after_display":"3,484,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-22","filed_date":"2017-05-24","scope":"insider"},{"id":9204547,"accession":"0000899243-17-028595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-028595","line_url":"/filing/0000899243-17-028595#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1125000.0,"total_display":"1,125,000.00","total_whole":"1,125,000","shares_owned_after":3409536.0,"shares_owned_after_display":"3,409,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-17","filed_date":"2017-12-13","scope":"insider"},{"id":8798647,"accession":"0001104659-15-049012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-15-049012","line_url":"/filing/0001104659-15-049012#line-3","is_derivative":false,"issuer_cik":"0001291884","issuer_name":"CATABASIS PHARMACEUTICALS INC","issuer_ticker":"CATB","issuer_name_source":null,"issuer_url":"/issuer/0001291884","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":223439.0,"shares_display":"223,439","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":2681268.0,"total_display":"2,681,268.00","total_whole":"2,681,268","shares_owned_after":1632652.0,"shares_owned_after_display":"1,632,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-06-30","scope":"insider"},{"id":8881939,"accession":"0001209191-15-018743","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-018743","line_url":"/filing/0001209191-15-018743#line-3","is_derivative":false,"issuer_cik":"0001281895","issuer_name":"INOTEK PHARMACEUTICALS CORP","issuer_ticker":"ITEK","issuer_name_source":null,"issuer_url":"/issuer/0001281895","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":416667.0,"shares_display":"416,667","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2500002.0,"total_display":"2,500,002.00","total_whole":"2,500,002","shares_owned_after":1917906.0,"shares_owned_after_display":"1,917,906","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-23","filed_date":"2015-02-25","scope":"insider"},{"id":6796722,"accession":"0001209191-14-024136","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-024136","line_url":"/filing/0001209191-14-024136#line-2","is_derivative":false,"issuer_cik":"0001273636","issuer_name":"APPLIED GENETIC TECHNOLOGIES CORP","issuer_ticker":"AGTC","issuer_name_source":null,"issuer_url":"/issuer/0001273636","owner_cik":"0001291884","owner_name":"MedImmune Ventures, Inc.","owner_display_name":"MedImmune Ventures, Inc.","owner_url":"/insider/0001291884","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75735.0,"shares_display":"75,735","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":908820.0,"total_display":"908,820.00","total_whole":"908,820","shares_owned_after":1452196.0,"shares_owned_after_display":"1,452,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Ten percent owner","n_filings":5,"first_seen":"2017-05-24","last_seen":"2017-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001454789","name":"CATABASIS PHARMACEUTICALS INC","url":"/issuer/0001454789","role":"Ten percent owner","n_filings":1,"first_seen":"2015-06-30","last_seen":"2015-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001281895","name":"INOTEK PHARMACEUTICALS CORP","url":"/issuer/0001281895","role":"Ten percent owner","n_filings":1,"first_seen":"2015-02-25","last_seen":"2015-02-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001273636","name":"APPLIED GENETIC TECHNOLOGIES CORP","url":"/issuer/0001273636","role":"Ten percent owner","n_filings":1,"first_seen":"2014-04-01","last_seen":"2014-04-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291884","retrieved_at":"2026-08-22T23:30:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}